Brain Biomarker of Endogenous Analgesia in Patients With Chronic Knee Pain
NCT05003323
Agnosia, Analgesia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT Number: NCT03556423
Introduction: Total knee arthroplasty (TKA) is an effective intervention to relieve people with osteoarthritis (OA). Nevertheless, 15 to 30% of patients continue to experience severe pain following surgery. Recent data suggest that central nervous system (CNS) changes may play a role in OA pain and possibly explain why some patients have poorer clinical outcomes following TKA. Objectives: Our main objectives are to explore the relationship between OA pain and (1) the integrity of corticospinal system, (2) the efficacy of descending pain inhibition circuits. Methods: Fifty-two patients waiting for TKA will be recruited. The integrity of the corticospinal projections will be measured using transcranial magnetic stimulation (recruitment curve of the affected quadriceps femoris muscle) and the descending pain inhibition circuits (bulbospinal projections) will be assessed by a counter-irritation paradigm (i.e., conditioned pain modulation with immersion of the arm in painfully cold water). Diffuse tension imaging (DTI) will also be used to quantify the strength of these corticospinal and bulbospinal projections. Clinical outcomes will be evaluated before and after arthroplasty with a series of validated questionnaires such as the WOMAC Scale, the McGill Pain Questionnaire and the Brief Pain Inventory. These different neurophysiological and clinical measures will be taken before surgery, 6 months after surgery and 1 year post-surgery. Anticipated results: The investigators expect a moderate association between pain and the strength of the corticospinal and bulbospinal projections. Moreover, it is expected that there will be a moderate association between the strength of the corticospinal/bulbospinal projections and the clinical evolution of patients.
Looking for future studies?
Notify Me50 year–79 year
All sexes
Observational
CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
See outcome measures
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by transcranial magnetic stimulation (TMS)
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by a counter-irritation paradigm (conditioned pain modulation using a thermode and a bath of circulating cold water)
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by a visual analogue scale (VAS). The VAS is a straight horizontal line of fixed length, usually 10 cm. The ends are defined as the extreme limits of the parameter to be measured; 0 = "no pain", 10 = "the worst imaginable pain". Using a ruler, the score is determined by measuring the distance (cm) on the 10 cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-10. A higher score indicates greater pain intensity.
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured with the Pain Catastrophizing Scale (PCS) . The PCS inquire participants to reflect on past painful experiences, and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain. Each item of the PCS is scored on a 5-point scale where 0 = not at all and 4 = all the time. PCS yields three subscale scores assessing rumination, magnification and helplessness. The PCS total score is computed by summing responses to all 13 items. The PCS yields a total score ranging from 0 to 52. Higher values on this scale represent a greater tendency of the subject to perceive pain negatively and to foresee the consequences of pain in a more catastrophic way.
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured with the Tampa Scale of Kinesiophobia (TSK) . The TSK is a 17-item self-report checklist using a 4-point Likert scale that was developed as a measure of fear of movement or (re)injury. The total score ranges between 17 and 68. A high value on the TSK indicates a high degree of kinesiophobia, and a cutoff score was developed by Vlaeyen (1995), where a score of 37 or over is considered as a high score, while scores below that are considered as low scores.
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured with the Spielberger's State-Trait Anxiety Inventory
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by the McGill Pain Questionnaire
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by the Brief Pain Inventory (BPI)
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by the SMAF questionnaire
Time frame: Before surgery, 6 months and 1 year post-surgery
Physical Activity Scale for the Elderly (PASE)
Time frame: Before surgery, 6 months and 1 year post-surgery
This outcome will be measured by the Central Sensitization Inventory
Université de Sherbrooke
Other
Pain in Individuals With Knee Osteoarthritis : Beyond the Joint and the Musculoskeletal System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05003323
Agnosia, Analgesia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06710782
Arthritis, Chronic Pain
Tanta, ElGharbia, Egypt
View Trial DetailsNCT05721352
Anxiety Disorders, Arthritis
Phoenix, Arizona, United States
View Trial DetailsNCT03425019
Arthritis, Chronic Pain
Houston, Texas, United States
View Trial Details